RELMADA THERAPEUTICS, INC.

A clinical-stage biotech developing novel therapies for CNS diseases and oncology.

RLMD | NDAQ

Overview

Corporate Details

ISIN(s):: US75954H1005 (+1 more)
LEI:
Country:: United States of America
Address:: 2222 PONCE DE LEON BLVD. 3RD FLOOR, 33134 CORAL GABLES
Website:: https://www.relmada.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative and novel treatments for debilitating disorders. The company's primary research area is central nervous system (CNS) diseases, with a significant focus on therapies for major depressive disorder (MDD), including its lead candidate esmethadone. Relmada is also advancing its development pipeline into oncology, with programs such as NDV-01 for urologic cancers. The company's mission is to create transformative medicines that improve human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:00	Regulatory News Service 8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)	English	34.7 MB

Automate Your Workflow. Get a real-time feed of all RELMADA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RELMADA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RELMADA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ROXX, Inc. HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.	Japan	241A
SAFTEC CO.,LTD. Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.	Japan	7464
Salarius Pharmaceuticals, Inc. Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.	United States of America	SLRX
Saniona Develops ion channel medicines for rare neurological diseases and epilepsy.	Denmark	SANION
Santech Holdings Ltd A technology company developing innovative consumer and enterprise technology businesses.	United States of America	STEC
SBI Leasing Services Co.,Ltd. Structures Japanese Operating Leases for aircraft & ships for corporate investors.	Japan	5834
Schrodinger, Inc. A physics-based computational platform for accelerated drug and materials discovery.	United States of America	SDGR
Sensorion Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.	France	ALSEN
SERENDIP HOLDINGS Co.,Ltd. Consulting & investment firm aiding manufacturing SMEs with M&A, succession, and revitalization.	Japan	7318
SEYFERT LTD. Provides recruitment, staffing, and education services for the beauty salon industry.	Japan	9213